HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation.

Abstract
Doxorubicin (DOX) is an effective chemotherapeutic agent used to treat a wide variety of malignancies. In addition to its multi-organ toxicity, DOX treatment has been shown to induce systemic inflammation in patients and experimental animals. Inflammation alters the expression of hepatic cytochrome P450 (CYP) enzymes, which play important roles in drug metabolism and DOX-induced toxicity. Significant sex differences have been reported in DOX-induced toxicity; however, sex differences in DOX-induced systemic inflammation and the potential effects on hepatic CYP expression have not been determined. In the current work, male and female C57Bl/6 mice were administered DOX (20 mg/kg by intraperitoneal injection), and groups of mice were sacrificed 24 and 72 h after DOX administration. DOX elicited a systemic inflammatory response in both male and female mice, but the inflammatory response was stronger in male mice. DOX altered the expression of hepatic CYP isoforms in a sex-dependent manner. Most notably, inhibition of Cyp2c29 and Cyp2e1 was stronger in male than in female mice, which paralleled the sex differences in systemic inflammation. Therefore, sex differences in DOX-induced systemic inflammation may lead to sexually dimorphic drug interactions, in addition to contributing to the previously reported sexual dimorphism in specific DOX-induced organ toxicity.
AuthorsMarianne K O Grant, Ibrahim Y Abdelgawad, Christine A Lewis, Beshay N Zordoky
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 21 Issue 4 (Feb 14 2020) ISSN: 1422-0067 [Electronic] Switzerland
PMID32074957 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Interleukin-6
  • Isoenzymes
  • Tumor Necrosis Factor-alpha
  • Doxorubicin
  • Cytochrome P-450 Enzyme System
Topics
  • Animals
  • Antibiotics, Antineoplastic (pharmacology)
  • Cytochrome P-450 Enzyme System (chemistry, genetics, metabolism)
  • Doxorubicin (pharmacology)
  • Female
  • Gene Expression Regulation (drug effects)
  • Inflammation (chemically induced, metabolism, pathology)
  • Injections, Intraperitoneal
  • Interleukin-6 (blood)
  • Isoenzymes (antagonists & inhibitors, genetics, metabolism)
  • Liver (enzymology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Sex Characteristics
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: